O95150
Gene name |
TNFSF15 (TL1, VEGI) |
Protein name |
Tumor necrosis factor ligand superfamily member 15 |
Names |
TNF ligand-related molecule 1, Vascular endothelial cell growth inhibitor |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:9966 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
8 structures for O95150
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 2O0O | X-ray | 300 A | A/B/C | 72-251 | PDB |
| 2QE3 | X-ray | 250 A | A | 72-251 | PDB |
| 2RE9 | X-ray | 210 A | A/B/C | 72-251 | PDB |
| 2RJK | X-ray | 230 A | A | 72-251 | PDB |
| 2RJL | X-ray | 205 A | A | 72-251 | PDB |
| 3K51 | X-ray | 245 A | A | 72-251 | PDB |
| 3MI8 | X-ray | 295 A | A | 72-251 | PDB |
| AF-O95150-F1 | Predicted | AlphaFoldDB |
195 variants for O95150
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs1564348710 CA374687431 |
2 | A>P | No |
ClinGen Ensembl |
|
|
CA5207096 rs371110841 |
3 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA5207095 rs765222060 |
6 | G>E | No |
ClinGen ExAC gnomAD |
|
|
rs1357593846 CA374687398 |
7 | L>P | No |
ClinGen gnomAD |
|
|
rs757409599 CA5207094 |
8 | S>N | No |
ClinGen ExAC gnomAD |
|
|
rs140689831 CA374687382 |
9 | F>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA374687386 rs1399648493 |
9 | F>S | No |
ClinGen gnomAD |
|
|
CA5207092 rs764654587 |
10 | G>R | No |
ClinGen ExAC gnomAD |
|
|
CA5207090 rs775935352 |
11 | E>D | No |
ClinGen ExAC gnomAD |
|
|
CA5207091 rs761282953 |
11 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374687370 rs1587903804 |
12 | T>P | No |
ClinGen Ensembl |
|
|
rs1218308722 CA374687364 |
13 | A>T | No |
ClinGen TOPMed |
|
|
CA5207088 rs369441005 CA5207087 |
14 | S>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs767994309 CA5207089 |
14 | S>R | No |
ClinGen ExAC gnomAD |
|
|
rs562601626 CA5207086 |
16 | E>K | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA374687333 rs1587903793 |
17 | M>I | No |
ClinGen Ensembl |
|
|
rs1047533515 CA198901216 |
20 | E>D | No |
ClinGen Ensembl |
|
|
CA198901217 rs56129146 |
20 | E>K | No |
ClinGen Ensembl |
|
|
CA5207085 rs146813484 |
21 | H>Q | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
| TCGA novel | 21 | H>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA374687306 rs768523743 |
22 | G>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5207082 rs576932402 |
22 | G>D | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA5207083 rs768523743 |
22 | G>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1400935280 CA374687287 |
25 | R>G | No |
ClinGen TOPMed |
|
|
rs150191342 RCV000904737 CA5207080 |
25 | R>K | No |
ClinGen ClinVar 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
|
rs150191342 CA374687285 |
25 | R>T | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA198901215 rs368232426 |
26 | P>L | No |
ClinGen ESP TOPMed |
|
|
CA374687279 rs1363558322 |
26 | P>S | No |
ClinGen TOPMed |
|
|
rs746059555 COSM1582778 CA5207079 |
27 | K>E | stomach [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
|
CA198901214 rs750605115 |
28 | A>T | No |
ClinGen Ensembl |
|
|
CA374687261 rs1279043315 |
29 | R>K | No |
ClinGen TOPMed |
|
|
CA5207078 rs779239225 |
30 | S>N | No |
ClinGen ExAC gnomAD |
|
|
rs757455616 CA5207077 |
31 | S>R | No |
ClinGen ExAC gnomAD |
|
|
rs140925489 CA5207076 |
32 | S>G | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs753318529 CA5207073 |
33 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5207074 rs753318529 |
33 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs55683440 CA5207072 |
34 | R>C | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA5207071 rs201981566 |
34 | R>H | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs201981566 CA198901213 |
34 | R>P | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs1233763127 CA374687220 |
36 | A>T | No |
ClinGen gnomAD |
|
|
rs772707672 CA5207070 |
36 | A>V | No |
ClinGen ExAC gnomAD |
|
|
rs377131025 CA5207069 |
37 | L>F | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA374687214 rs377131025 |
37 | L>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1160125356 CA374687182 |
42 | V>L | No |
ClinGen TOPMed |
|
|
rs142809540 CA198901212 |
43 | L>W | No |
ClinGen ESP |
|
|
CA374687163 rs1587903714 |
45 | P>S | No |
ClinGen Ensembl |
|
|
CA374687153 rs1365054184 |
46 | F>L | No |
ClinGen TOPMed gnomAD |
|
|
rs1320756540 CA374687147 |
47 | L>P | No |
ClinGen gnomAD |
|
|
rs866462140 CA198901210 |
48 | A>T | No |
ClinGen Ensembl |
|
|
rs761388330 CA5207067 |
48 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs776054186 CA5207066 |
49 | G>E | No |
ClinGen ExAC gnomAD |
|
|
CA374687133 rs1392705533 |
50 | L>H | No |
ClinGen TOPMed |
|
|
CA5207065 rs768222774 |
51 | T>I | No |
ClinGen ExAC gnomAD |
|
|
CA198901208 rs961818106 |
56 | V>L | No |
ClinGen TOPMed |
|
|
CA5207062 rs771826971 |
57 | S>R | No |
ClinGen ExAC gnomAD |
|
|
rs527825986 CA198901207 |
58 | Q>R | No |
ClinGen Ensembl |
|
|
CA374687078 rs745637627 |
59 | L>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5207061 rs745637627 |
59 | L>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA198901206 rs1028941301 |
60 | R>Q | No |
ClinGen TOPMed gnomAD |
|
|
CA5207060 rs554137268 |
60 | R>W | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs1271897082 CA374687071 |
61 | A>S | No |
ClinGen gnomAD |
|
|
CA374687066 rs1294409455 |
62 | Q>E | No |
ClinGen TOPMed |
|
|
rs1294409455 CA374687067 |
62 | Q>K | No |
ClinGen TOPMed |
|
|
CA374687063 rs749472080 |
62 | Q>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5207058 rs749472080 |
62 | Q>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5207057 rs777991000 |
63 | G>E | No |
ClinGen ExAC gnomAD |
|
|
rs756319889 CA5207056 |
65 | A>V | No |
ClinGen ExAC |
|
|
CA374687037 rs1374591489 |
66 | C>F | No |
ClinGen TOPMed gnomAD |
|
|
CA374687039 rs1374591489 |
66 | C>Y | No |
ClinGen TOPMed gnomAD |
|
|
rs781774264 CA5207054 |
67 | V>A | No |
ClinGen ExAC gnomAD |
|
|
rs537486487 CA5207055 |
67 | V>L | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA374687019 rs1587903647 |
69 | F>Y | No |
ClinGen Ensembl |
|
|
rs1290124561 CA374687012 |
70 | Q>* | No |
ClinGen gnomAD |
|
| TCGA novel | 72 | L>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA374686981 rs1240942553 |
72 | L>P | No |
ClinGen gnomAD |
|
|
CA5207033 rs780453763 |
73 | K>E | No |
ClinGen ExAC gnomAD |
|
|
CA5207032 rs201039485 |
76 | E>K | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs753461731 CA5207031 |
79 | P>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374686921 rs1206745818 |
81 | H>R | No |
ClinGen gnomAD |
|
|
CA374686910 rs1446425593 |
82 | Q>H | No |
ClinGen gnomAD |
|
|
rs1290489216 CA374686909 |
83 | Q>* | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs1461120016 CA374686876 |
85 | Y>* | No |
ClinGen gnomAD |
|
|
CA374686864 rs1254888631 |
87 | P>H | No |
ClinGen TOPMed gnomAD |
|
|
rs768751032 CA5207001 |
88 | L>F | No |
ClinGen ExAC gnomAD |
|
|
rs747024209 CA5207000 |
88 | L>P | No |
ClinGen ExAC gnomAD |
|
|
rs1468026647 CA374686858 |
89 | R>G | No |
ClinGen gnomAD |
|
|
rs1428574713 CA374686855 |
89 | R>I | No |
ClinGen gnomAD |
|
|
CA374686856 rs1428574713 |
89 | R>T | No |
ClinGen gnomAD |
|
|
CA374686849 rs1159774940 |
90 | A>E | No |
ClinGen gnomAD |
|
|
CA5206999 rs775666236 |
91 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA198899766 rs866972093 |
92 | G>E | No |
ClinGen Ensembl |
|
|
rs746375852 CA5206997 |
92 | G>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1238253306 CA374686819 |
95 | P>T | No |
ClinGen gnomAD |
|
|
CA5206995 rs757672135 |
96 | R>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs747809936 CA5206994 |
97 | A>S | No |
ClinGen ExAC gnomAD |
|
|
rs550636247 CA5206970 |
104 | Q>E | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA5206968 rs200936418 |
104 | Q>H | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs550636247 CA5206969 |
104 | Q>K | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs565550412 CA5206966 |
106 | P>R | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs763957233 CA5206964 |
107 | T>I | No |
ClinGen ExAC gnomAD |
|
|
CA5206965 rs753523598 |
107 | T>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5206962 rs753019245 |
108 | Q>P | No |
ClinGen ExAC gnomAD |
|
|
rs753019245 CA5206963 |
108 | Q>R | No |
ClinGen ExAC gnomAD |
|
|
CA374686563 rs372685008 |
109 | H>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs201333233 CA5206958 |
109 | H>P | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs201333233 CA5206959 |
109 | H>R | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs372685008 CA5206960 |
109 | H>Y | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
RCV000947201 CA5206957 VAR_043130 rs16931745 |
110 | F>L | No |
ClinGen ClinVar UniProt 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
|
CA374686548 rs1169435031 |
111 | K>R | No |
ClinGen gnomAD |
|
|
rs773380295 CA5206956 |
112 | N>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs770252535 CA5206955 |
113 | Q>L | No |
ClinGen ExAC gnomAD |
|
|
CA5206954 rs746621637 |
114 | F>Y | No |
ClinGen ExAC gnomAD |
|
|
CA5206953 rs779892512 |
116 | A>T | No |
ClinGen ExAC |
|
|
CA5206952 rs771882145 |
117 | L>P | No |
ClinGen ExAC gnomAD |
|
|
rs918842271 CA198899603 |
125 | L>Q | No |
ClinGen gnomAD |
|
|
CA5206948 rs753883025 |
126 | A>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs757078623 CA5206949 |
126 | A>T | No |
ClinGen ExAC gnomAD |
|
|
rs1197127247 CA374686444 |
127 | F>S | No |
ClinGen gnomAD |
|
|
rs752880973 CA5206945 |
131 | R>* | No |
ClinGen ExAC gnomAD |
|
|
CA5206944 rs370931148 |
131 | R>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1403226813 CA374686413 |
132 | M>L | No |
ClinGen TOPMed gnomAD |
|
|
rs1403226813 CA374686414 |
132 | M>V | No |
ClinGen TOPMed gnomAD |
|
|
rs192783899 CA374686401 CA374686400 |
133 | N>K | No |
ClinGen 1000Genomes TOPMed gnomAD |
|
|
rs888774101 CA198899600 |
133 | N>S | No |
ClinGen TOPMed |
|
|
CA198899598 rs749946059 |
135 | T>A | No |
ClinGen Ensembl |
|
|
CA198899596 rs867957370 |
138 | F>L | No |
ClinGen Ensembl |
|
|
rs1043903510 CA198899595 |
141 | I>N | No |
ClinGen TOPMed |
|
|
CA374686336 rs1477177470 |
143 | E>V | No |
ClinGen Ensembl |
|
|
CA5206942 rs368084272 COSM201943 |
144 | S>L | Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA374686327 rs1332192451 |
145 | G>R | No |
ClinGen TOPMed |
|
|
rs763364067 CA5206940 |
155 | F>L | No |
ClinGen ExAC gnomAD |
|
|
CA374686255 rs1192129602 |
155 | F>Y | No |
ClinGen gnomAD |
|
|
CA5206939 rs370283022 |
156 | R>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA |
|
CA5206938 rs139705441 |
156 | R>H | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1564344186 CA374686235 |
158 | M>I | No |
ClinGen Ensembl |
|
|
CA5206936 rs777159050 |
158 | M>L | No |
ClinGen ExAC gnomAD |
|
|
CA374686232 rs1251829228 |
159 | T>A | No |
ClinGen gnomAD |
|
|
CA374686228 rs771795926 |
159 | T>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs771795926 CA5206935 |
159 | T>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374686226 rs1249364761 |
160 | S>P | No |
ClinGen TOPMed gnomAD |
|
|
CA5206933 rs773998277 |
161 | E>Q | No |
ClinGen ExAC gnomAD |
|
|
CA198899593 rs764896114 |
162 | C>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
rs200996697 CA5206931 |
163 | S>R | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs557041991 CA374686161 |
169 | G>D | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA5206929 rs756034226 |
169 | G>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5206928 rs557041991 |
169 | G>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1334265183 CA374686159 COSM1104430 |
170 | R>* | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
|
rs144487361 CA374686157 |
170 | R>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs144487361 CA5206927 |
170 | R>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA5206926 rs755125917 |
171 | P>S | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA374686151 rs1408692404 |
172 | N>D | No |
ClinGen gnomAD |
|
|
rs867213148 CA198899591 |
176 | S>F | No |
ClinGen Ensembl |
|
|
CA374686120 rs1335329920 |
176 | S>P | No |
ClinGen gnomAD |
|
|
CA374686105 rs1469676476 |
178 | T>S | No |
ClinGen TOPMed gnomAD |
|
|
CA5206923 rs149700202 |
182 | T>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
rs149700202 CA5206924 |
182 | T>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs928228400 CA198899590 |
183 | K>R | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 184 | V>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1468135390 CA374686063 |
185 | T>R | No |
ClinGen gnomAD |
|
|
rs750502102 CA5206922 |
186 | D>E | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
| TCGA novel | 186 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1218000940 CA374686051 |
187 | S>N | No |
ClinGen gnomAD |
|
|
rs764624230 CA5206919 |
188 | Y>* | No |
ClinGen ExAC gnomAD |
|
|
rs762427267 CA5206920 |
188 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs765727909 CA5206921 |
188 | Y>D | No |
ClinGen ExAC gnomAD |
|
|
CA198899589 rs371091768 |
191 | P>S | No |
ClinGen ESP TOPMed gnomAD |
|
|
rs371091768 CA374686026 |
191 | P>T | No |
ClinGen ESP TOPMed gnomAD |
|
|
CA374686017 rs1225587127 |
192 | T>I | No |
ClinGen gnomAD |
|
|
CA198899588 rs893642296 |
194 | L>F | No |
ClinGen Ensembl |
|
| TCGA novel | 194 | L>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA5206916 rs774192671 |
196 | M>T | No |
ClinGen ExAC |
|
|
rs1587897491 CA374685984 |
197 | G>V | No |
ClinGen Ensembl |
|
|
rs150498686 CA5206910 |
203 | E>K | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA5206909 rs754824293 |
204 | V>A | No |
ClinGen ExAC gnomAD |
|
|
rs747201293 CA5206908 |
205 | G>S | No |
ClinGen ExAC gnomAD |
|
|
rs1389685315 CA374685933 |
205 | G>V | No |
ClinGen gnomAD |
|
| TCGA novel | 208 | W>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs895341787 CA198899587 |
213 | Y>* | No |
ClinGen Ensembl |
|
|
CA5206906 rs758572471 |
215 | G>R | Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs1298405818 CA374685850 |
217 | M>R | No |
ClinGen gnomAD |
|
|
CA374685817 rs1463136556 |
221 | Q>H | No |
ClinGen gnomAD |
|
|
CA374685809 rs1383002485 |
222 | E>D | No |
ClinGen gnomAD |
|
|
CA374685804 rs1182824443 |
223 | G>E | No |
ClinGen gnomAD |
|
|
CA5206903 rs138476552 |
227 | M>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA374685760 rs754459102 |
229 | N>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA198899585 rs889534030 |
230 | V>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
|
CA374685742 rs1445362541 |
232 | D>G | No |
ClinGen gnomAD |
|
|
rs1283563027 CA374685737 |
233 | I>V | No |
ClinGen gnomAD |
|
|
CA198899583 rs7027251 |
240 | K>* | No |
ClinGen Ensembl |
|
|
rs1223310365 COSM3847459 CA374685652 |
245 | F>L | breast [Cosmic] | No |
ClinGen cosmic curated gnomAD |
|
rs764534409 CA5206901 |
248 | A>D | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 248 | A>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs901641124 CA198899582 |
248 | A>T | No |
ClinGen TOPMed |
|
|
rs1177866256 CA374685611 |
251 | L>V | No |
ClinGen TOPMed |
|
|
CA374685607 rs1245749056 |
252 | L>Q | No |
ClinGen gnomAD |
No associated diseases with O95150
1 regional properties for O95150
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Tumour necrosis factor domain | 95 - 251 | IPR006052 |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| cytokine activity | The activity of a soluble extracellular gene product that interacts with a receptor to effect a change in the activity of the receptor to control the survival, growth, differentiation and effector function of tissues and cells. |
| signaling receptor binding | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| tumor necrosis factor receptor binding | Binding to a tumor necrosis factor receptor. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| activation of cysteine-type endopeptidase activity involved in apoptotic process | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| activation of NF-kappaB-inducing kinase activity | The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues. |
| apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| immune response | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
1 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q8K3Y7 | Tnfsf15 | Tumor necrosis factor ligand superfamily member 15 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAEDLGLSFG | ETASVEMLPE | HGSCRPKARS | SSARWALTCC | LVLLPFLAGL | TTYLLVSQLR |
| 70 | 80 | 90 | 100 | 110 | 120 |
| AQGEACVQFQ | ALKGQEFAPS | HQQVYAPLRA | DGDKPRAHLT | VVRQTPTQHF | KNQFPALHWE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| HELGLAFTKN | RMNYTNKFLL | IPESGDYFIY | SQVTFRGMTS | ECSEIRQAGR | PNKPDSITVV |
| 190 | 200 | 210 | 220 | 230 | 240 |
| ITKVTDSYPE | PTQLLMGTKS | VCEVGSNWFQ | PIYLGAMFSL | QEGDKLMVNV | SDISLVDYTK |
| 250 | |||||
| EDKTFFGAFL | L |